Abir Tadmouri

492 total citations
19 papers, 311 citations indexed

About

Abir Tadmouri is a scholar working on Physiology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Abir Tadmouri has authored 19 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Molecular Biology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Abir Tadmouri's work include Clinical Nutrition and Gastroenterology (3 papers), Ion channel regulation and function (3 papers) and Inflammatory Myopathies and Dermatomyositis (3 papers). Abir Tadmouri is often cited by papers focused on Clinical Nutrition and Gastroenterology (3 papers), Ion channel regulation and function (3 papers) and Inflammatory Myopathies and Dermatomyositis (3 papers). Abir Tadmouri collaborates with scholars based in France, Lebanon and Italy. Abir Tadmouri's co-authors include J. Champagnat, Marie‐Pierre Morin‐Surun, Axel Balian, Pierre Sénesse, Patrick Seys, C. Chambrier, Michel De Waard, Stéphane Culine, P. Dufour and Mohamad A. Mikati and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

Abir Tadmouri

18 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abir Tadmouri France 11 97 87 67 46 43 19 311
C. M. Hall United Kingdom 12 82 0.8× 177 2.0× 62 0.9× 59 1.3× 71 1.7× 14 490
Giselda Maria Kalil de Cabello Brazil 12 51 0.5× 57 0.7× 46 0.7× 14 0.3× 18 0.4× 26 301
Panagiotis Mylonas Greece 9 85 0.9× 43 0.5× 24 0.4× 22 0.5× 79 1.8× 13 319
Hans Axelsson Sweden 11 66 0.7× 74 0.9× 28 0.4× 9 0.2× 59 1.4× 25 333
Athina Xaidara Greece 10 60 0.6× 121 1.4× 8 0.1× 21 0.5× 55 1.3× 21 355
Randall M. Wilson United States 7 59 0.6× 62 0.7× 20 0.3× 134 2.9× 17 0.4× 7 295
Siddharth Krishnan United Kingdom 9 90 0.9× 92 1.1× 17 0.3× 8 0.2× 25 0.6× 13 489
Susanne Bierschenk Germany 7 85 0.9× 91 1.0× 12 0.2× 15 0.3× 24 0.6× 9 432
Paula F. Moon-Massat United States 13 87 0.9× 128 1.5× 6 0.1× 50 1.1× 42 1.0× 34 478
T. Trueman United Kingdom 7 50 0.5× 31 0.4× 24 0.4× 44 1.0× 58 1.3× 8 305

Countries citing papers authored by Abir Tadmouri

Since Specialization
Citations

This map shows the geographic impact of Abir Tadmouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abir Tadmouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abir Tadmouri more than expected).

Fields of papers citing papers by Abir Tadmouri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abir Tadmouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abir Tadmouri. The network helps show where Abir Tadmouri may publish in the future.

Co-authorship network of co-authors of Abir Tadmouri

This figure shows the co-authorship network connecting the top 25 collaborators of Abir Tadmouri. A scholar is included among the top collaborators of Abir Tadmouri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abir Tadmouri. Abir Tadmouri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
García‐Alfonso, Pilar, et al.. (2022). Systematic review of randomised clinical trials and observational studies for patients with RAS wild-type or BRAF-mutant metastatic and/or unresectable colorectal cancer. Critical Reviews in Oncology/Hematology. 173. 103646–103646. 5 indexed citations
2.
Mohr, Peter, et al.. (2020). 1140P A digital companion for patients with BRAF-mutant advanced melanoma treated with targeted therapies: TAVIE skin app. Annals of Oncology. 31. S763–S763. 2 indexed citations
4.
Latour, Régis Peffault de, Patrice Chevallier, Didier Blaise, et al.. (2020). Clinical and economic impact of treated CMV infection in adult CMV‐seropositive patients after allogeneic hematopoietic cell transplantation. Journal of Medical Virology. 92(12). 3665–3673. 9 indexed citations
5.
Crave, Jean‐Charles, et al.. (2018). Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases. Autoimmunity Reviews. 17(9). 873–881. 12 indexed citations
6.
Dutriaux, Caroline, Philippe Saïag, Nicolás Meyer, et al.. (2018). Outcomes of elderly treated with pembrolizumab for metastatic melanoma comparing with younger patients.. Journal of Clinical Oncology. 36(15_suppl). e21508–e21508. 1 indexed citations
7.
Saïag, Philippe, Laurent Mortier, Caroline Dutriaux, et al.. (2018). Impact of simultaneous radiotherapy in melanoma patients treated with pembrolizumab in the French early access program.. Journal of Clinical Oncology. 36(15_suppl). 9555–9555. 2 indexed citations
8.
Chérìn, P., et al.. (2018). Assessment of renal function in patients with myositis and treated with subcutaneous immunoglobulin: a series of 24 cases. Therapeutic Advances in Musculoskeletal Disease. 10(10). 201–207. 3 indexed citations
11.
Ruiz, Fabrice, et al.. (2016). Preliminary development of a tool assessing the acceptability of medicines for paediatric use. International Journal of Pharmaceutics. 511(2). 1146–1147. 1 indexed citations
12.
Bousquet, Philippe‐Jean, Philippe Devillier, Abir Tadmouri, et al.. (2015). Clinical Relevance of Cluster Analysis in Phenotyping Allergic Rhinitis in a Real-Life Study. International Archives of Allergy and Immunology. 166(3). 231–240. 18 indexed citations
13.
Seys, Patrick, Abir Tadmouri, Pierre Sénesse, et al.. (2014). Nutrition parentérale à domicile chez la personne âgée atteinte d’un cancer : une étude observationnelle prospective. Bulletin du Cancer. 101(3). 243–249. 12 indexed citations
14.
Sénesse, Pierre, Abir Tadmouri, Stéphane Culine, et al.. (2014). A Prospective Observational Study Assessing Home Parenteral Nutrition in Patients With Gastrointestinal Cancer: Benefits for Quality of Life. Journal of Pain and Symptom Management. 49(2). 183–191.e2. 34 indexed citations
15.
Culine, Stéphane, C. Chambrier, Abir Tadmouri, et al.. (2014). Home parenteral nutrition improves quality of life and nutritional status in patients with cancer: a French observational multicentre study. Supportive Care in Cancer. 22(7). 1867–1874. 58 indexed citations
16.
Tadmouri, Abir, J. Champagnat, & Marie‐Pierre Morin‐Surun. (2014). Activation of microglia and astrocytes in the nucleus tractus solitarius during ventilatory acclimatization to 10% hypoxia in unanesthetized mice. Journal of Neuroscience Research. 92(5). 627–633. 42 indexed citations
17.
Weiss, Norbert, Abir Tadmouri, Mohamad A. Mikati, Michel Ronjat, & Michel De Waard. (2006). Importance of voltage-dependent inactivation in N-type calcium channel regulation by G-proteins. Pflügers Archiv - European Journal of Physiology. 454(1). 115–129. 13 indexed citations
18.
Sandoval, Alejandro, et al.. (2006). Two PEST‐like motifs regulate Ca2+/calpain‐mediated cleavage of the CaVβ3 subunit and provide important determinants for neuronal Ca2+ channel activity. European Journal of Neuroscience. 23(9). 2311–2320. 19 indexed citations
19.
Boisseau, Sylvie, Kamel Mabrouk, Nicolas Garmy, et al.. (2006). Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1758(3). 308–319. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026